Alpha 2.0
Login Register
» Authors » Myra E van Linde

Myra E van Linde

Explore the profile of Myra E van Linde including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 27
Citations 586
Followers 0
Related Specialties
Oncology
General Medicine
Neurology
Top 10 Co-Authors
Henk M W Verheul
Joost Dekker
Cyrillo G Brahm
Philip C de Witt Hamer
Annemiek M E Walenkamp
Jaap C Reijneveld
Annemarie M J Braamse
Annemarie Becker-Commissaris
Aartjan T F Beekman
Anouk S Schuit
Published In
J Neurooncol
Neurooncol Adv
J Cancer Surviv
Oncologist
Cancers (Basel)
Affiliations
Soon will be listed here.
Recent Articles
1.
The STELLAR trial: a phase II/III randomized trial of high-dose, intermittent sunitinib in patients with recurrent glioblastoma
Janssen J, Brahm C, Driessen C, Nuver J, Labots M, Kouwenhoven M, et al.
Brain Commun . 2024 Aug; 6(4):fcae241. PMID: 39114330
Previously, the tyrosine kinase inhibitor sunitinib failed to show clinical benefit in patients with recurrent glioblastoma. Low intratumoural sunitinib accumulation in glioblastoma patients was reported as a possible explanation for...
2.
Decline in Smartphone-Assessed Physical Activity Level is Associated With Clinical Outcomes in Phase I/II Clinical Cancer Trials
Brouwer C, Douma J, Kuip E, Zweegman S, van de Donk N, Hopman M, et al.
J Natl Compr Canc Netw . 2024 May; 22(5):323-330. PMID: 38776960
Background: A decline in physical function may be an early predictor for complications of cancer treatment. This study examined whether repeated objective smartphone measurements of physical activity and exercise capacity...
3.
Network analysis used to investigate the interplay among somatic and psychological symptoms in patients with cancer and cancer survivors: a scoping review
Doppenberg-Smit G, Lamers F, van Linde M, Braamse A, Sprangers M, Beekman A, et al.
J Cancer Surviv . 2024 Mar; PMID: 38530627
Purpose: Patients with cancer often experience multiple somatic and psychological symptoms. Somatic and psychological symptoms are thought to be connected and may reinforce each other. Network analysis allows examination of...
4.
Frequency and burden of potentially treatable symptoms in glioma patients with stable disease
Rottgering J, Belgers V, Kouwenhoven M, Schuur M, Postma T, Nijboer C, et al.
Heliyon . 2023 Feb; 9(2):e13278. PMID: 36798771
Background & Aims: Glioma patients experience a multitude of symptoms that negatively affect their health-related quality of life. Symptoms vary greatly across disease phases, and the patients' stable phase might...
5.
Study protocol of the GLOW study: maximising treatment options for recurrent glioblastoma patients by whole genome sequencing-based diagnostics-a prospective multicenter cohort study
van Opijnen M, Broekman M, de Vos F, Cuppen E, van der Hoeven J, van Linde M, et al.
BMC Med Genomics . 2022 Nov; 15(1):233. PMID: 36333718
Background: Glioblastoma (GBM), the most common glial primary brain tumour, is without exception lethal. Every year approximately 600 patients are diagnosed with this heterogeneous disease in The Netherlands. Despite neurosurgery,...
6.
Cost-Utility of the eHealth Application 'Oncokompas', Supporting Incurably Ill Cancer Patients to Self-Manage Their Cancer-Related Symptoms: Results of a Randomized Controlled Trial
Schuit A, Holtmaat K, Coupe V, Eerenstein S, Zijlstra J, Eeltink C, et al.
Curr Oncol . 2022 Sep; 29(9):6186-6202. PMID: 36135055
Evidence on the cost-effectiveness of eHealth in palliative care is scarce. Oncokompas, a fully automated behavioral intervention technology, aims to support self-management in cancer patients. This study aimed to assess...
7.
Cannabinoids to Improve Health-Related Quality of Life in Patients with Neurological or Oncological Disease: A Meta-Analysis
Belgers V, Rottgering J, Douw L, Klein M, Ket J, van de Ven P, et al.
Cannabis Cannabinoid Res . 2022 Jul; 8(1):41-55. PMID: 35861789
Cannabinoids have been suggested to alleviate frequently experienced symptoms of reduced mental well-being such as anxiety and depression. Mental well-being is an important subdomain of health-related quality of life (HRQoL)....
8.
Rare central nervous system tumors in adults: a population-based study of ependymomas, pilocytic astrocytomas, medulloblastomas, and intracranial germ cell tumors
Ho V, Gijtenbeek A, Wagemakers M, Taal W, van Linde M, Swaak-Kragten A, et al.
Neurooncol Adv . 2022 Jun; 4(1):vdac062. PMID: 35664556
Background: Ependymomas, pilocytic astrocytomas, medulloblastomas, and intracranial germ cell tumors occur relative frequently in children, but are rare central nervous system (CNS) tumors in adults. In this population-based survey, we...
9.
Efficacy of the eHealth application Oncokompas, facilitating incurably ill cancer patients to self-manage their palliative care needs: A randomized controlled trial
Schuit A, Holtmaat K, Lissenberg-Witte B, Eerenstein S, Zijlstra J, Eeltink C, et al.
Lancet Reg Health Eur . 2022 May; 18:100390. PMID: 35496496
Background: Many patients with incurable cancer have symptoms affecting their health-related quality of life. The eHealth application 'Oncokompas' supports patients to take an active role in managing their palliative care...
10.
Temozolomide and Radiotherapy versus Radiotherapy Alone in Patients with Glioblastoma, IDH-wildtype: Post Hoc Analysis of the EORTC Randomized Phase III CATNON Trial
Tesileanu C, Sanson M, Wick W, Brandes A, Clement P, Erridge S, et al.
Clin Cancer Res . 2022 Mar; 28(12):2527-2535. PMID: 35275197
Purpose: In a post hoc analysis of the CATNON trial (NCT00626990), we explored whether adding temozolomide to radiotherapy improves outcome in patients with IDH1/2 wildtype (wt) anaplastic astrocytomas with molecular...